News

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
There’s new uncertainty about updated COVID-19 shots this fall after the Trump administration’s handling of a shot from ...
Receiving a COVID-19 booster vaccine in the same arm as the first vaccine dose leads to a faster, more effective immune ...
A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...
The potential change outlined in a statement would require all new vaccines to undergo “placebo” testing, sparking concerns ...
The Health and Human Services secretary intends to shift the way vaccines are tested, a move that the agency said will ...
Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...
Novavax's protein-only vaccine is once again expected to move from emergency approval to full approval status following a pause.
A Cleveland Clinic web page describing myocarditis survival rates was misrepresented online as news that millions who received COVID-19 vaccines were about to die.
Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...
Trinity College Dublin researchers have found that the BNT162b2 COVID-19 vaccine may offer protection beyond its intended ...
Lawsuit backed by Secretary Kennedy’s former non-profit says CDC is forcing disadvantaged kids to be vaccinated.